NCT05886491
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05886491
Title A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Takeda
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham (UAB) Hospital Birmingham Alabama 35205-5802 United States Details
City of Hope Duarte California 91010-3012 United States Details
Stanford University Palo Alto California 94304-1812 United States Details
Sarah Cannon/CBCI Denver Colorado 80218-1258 United States Details
Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611-3124 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University St Louis Missouri 63110-1010 United States Details
Roswell Park Comprehensive Cancer Center Buffalo New York 14263-0001 United States Details
Thomas Jefferson University New York New York 10065-4870 United States Details
Cleveland Clinic Cleveland Ohio 44195-0001 United States Details
OHSU Knight Cancer Institute Portland Oregon 97239-3011 United States Details
Tri-Star BMT/Sarah Cannon Nashville Nashville Tennessee 37203-6521 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Medical College of Wisconsin Milwaukee Wisconsin 53226-3522 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field